Inscription Capital »

Vanda Pharmaceuticals shares owned by Inscription Capital

Quarter-by-quarter ownership of Vanda Pharmaceuticals (VNDA) shares owned by Inscription Capital from 13F filings

Historical chart of Inscription Capital investment in Vanda Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Vanda Pharmaceuticals held by Inscription Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vanda Pharmaceuticals by Inscription Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $81k 16k 4.99

More positions owned by Inscription Capital

Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)
Pgim Etf Tr Pgim Ultra Sh Bd (PULS)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Nike CL B (NKE)
Pgim Etf Tr Aaa Clo Etf (PAAA)
Chevron Corporation (CVX)
Goldman Sachs Etf Tr Ultra Short Bond (GSST)

View all positions for Inscription Capital

Top funds holding Vanda Pharmaceuticals

BlackRock
Vanguard Group
Renaissance Technologies
Millennium Management
Dimensional Fund Advisors
Tang Capital Management
Acadian Asset Management
Geode Capital Management
State Street Corporation
Krensavage Asset Management
Two Sigma Advisers
Connor, Clark & Lunn Investment Management
Morgan Stanley
Empire Financial Management Company
Federated Investors

View all funds holding Vanda Pharmaceuticals